Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fadwa el Banoua"'
Autor:
Emilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, Fadwa El Banoua, Belen Ferrer, Juan A. Flores, Beatriz Galan-Rodriguez
Publikováno v:
Neurobiology of Disease, Vol 18, Iss 3, Pp 591-601 (2005)
We have observed that systemic administration of cannabinoid CB1 antagonists exerts antiparkinsonian effects in rats with very severe nigral lesion (>95% cell loss), but not in rats with less severe lesion (85–95% cell loss). Local injections into
Externí odkaz:
https://doaj.org/article/d4f6dd23bfa64285972aef3ece602906
Autor:
Fadwa El Banoua, Isabel Caraballo, Juan A Flores, Beatriz Galan-Rodriguez, Emilio Fernandez-Espejo
Publikováno v:
Neurobiology of Disease, Vol 16, Iss 2, Pp 377-385 (2004)
Brain cannabinoid CB1 receptors are expressed in neural areas that contribute to movement such as basal ganglia, where they co-localize with dopamine D1 and D2 receptors. The objective of the present study was to further study the functional role of
Externí odkaz:
https://doaj.org/article/43dd1eb9526b4ba78e472037c064aba1
Autor:
Emilio Fernández-Espejo, Beatriz Galan-Rodriguez, Fadwa El Banoua, Isabel Caraballo, Juan A. Flores
Publikováno v:
Neurobiology of Disease, Vol 16, Iss 2, Pp 377-385 (2004)
Brain cannabinoid CB(1) receptors are expressed in neural areas that contribute to movement such as basal ganglia, where they co-localize with dopamine D(1) and D(2) receptors. The objective of the present study was to further study the functional ro
Publikováno v:
Pain. 110:205-214
The periaqueductal grey (PAG) area is involved in pain modulation as well as in opiate-induced anti-nociceptive effects. The PAG possess dopamine neurons, and it is likely that this dopaminergic network participates in anti-nociception. The objective
Autor:
Fadwa El Banoua, Beatriz Galan-Rodriguez, Juan A. Flores, Belen Ferrer, Isabel Caraballo, Fernando Rodríguez de Fonseca, Emilio Fernández-Espejo
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 29(6)
Modulation of the endocannabinoid system might be useful in treating Parkinson's disease. Here, we show that systemic administration of N-(4-hydroxyphenyl)-arachidonamide (AM404), a cannabinoid modulator that enhances anandamide (AEA) availability in
Autor:
Isabel Caraballo, Beatriz Galan-Rodriguez, Belen Ferrer, Emilio Fernández-Espejo, Juan A. Flores, Fernando Rodríguez de Fonseca, Fadwa El Banoua
Publikováno v:
Neurobiology of Disease, Vol 18, Iss 3, Pp 591-601 (2005)
We have observed that systemic administration of cannabinoid CB1 antagonists exerts antiparkinsonian effects in rats with very severe nigral lesion (>95% cell loss), but not in rats with less severe lesion (85–95% cell loss). Local injections into
Autor:
Jose Luis López, Antonio Macho, Mario Alves, Fadwa el Banoua, Arturo San Feliciano, Eduardo Muñoz, Esther del Olmo
Publikováno v:
ChemInform. 34
Autor:
Arturo San Feliciano, Mario Alves, Fadwa el Banoua, Eduardo Muñoz, Esther del Olmo, Antonio Macho, Jose Luis López
Publikováno v:
Bioorganicmedicinal chemistry letters. 12(18)
A number of long chain diamines and aminoalcohols and several of their alkyl, acyl and carbamoyl derivatives, have been synthesized and evaluated for their apoptotic activities using the Jurkat cell line. Apoptosis was measured by flow cytometry and
Autor:
Emilio Fernandez Espejo, Isabel Caraballo, Juan A. Flores, Fadwa El Banoua, Joao-Paulo Moraes, M. Carmen Gonzalez-Albo
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 21(24)
Intrabrain transplantation of chromaffin cell aggregates of the Zuckerkandl's organ, an extra-adrenal paraganglion that has never been tested for antiparkinsonian treatment, induced gradual improvement of functional deficits in parkinsonian rats. The
Publikováno v:
Journal of Physiology; Dec2003 Supplement, Vol. 548, p1P-4P, 4p